Akebia saponin D ameliorates metabolic syndrome (MetS) via remodeling gut microbiota and attenuating intestinal barrier injury

Akebia saponin D ameliorates metabolic syndrome (MetS) via remodeling gut microbiota and attenuating intestinal barrier injury

Metabolic syndrome (MetS) is a complex, multifactorial disease which lead to an increased risk of cardiovascular disease, type 2 diabetes, and stroke. However, selective, and potent drugs for the treatment of MetS are still lacking. Previous studies have found that Akebia saponin D (ASD) has benefic...

Full description

Bibliographic Details
Main Authors: Song Yang, Ting Hu, He Liu, Ya-li Lv, Wen Zhang, Han Li, Lingling Xuan, Li-li Gong, Li-hong Liu
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Akebia saponin D
Gut microbiota
Metabolic syndrome
Gut barrier
PPAR-γ-FABP4
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332221002262

Internet

http://www.sciencedirect.com/science/article/pii/S0753332221002262

Similar Items